Israel -
hebreiska -
Ministry of Health
נינלארו 3 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 3 mg - ixazomib
Israel -
hebreiska -
Ministry of Health
נינלארו 4 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 4 mg - ixazomib
Israel -
hebreiska -
Ministry of Health
נינלארו 4 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 4 mg - ixazomib
Israel -
hebreiska -
Ministry of Health
מבטרה 10 מגמל תוך ורידי
roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu
Israel -
hebreiska -
Ministry of Health
טרוקסימה
padagis israel agencies ltd, israel - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab
Israel -
hebreiska -
Ministry of Health
מבטרה 1400 מג s.c
roche pharmaceuticals (israel) ltd - rituximab - תמיסה להזרקה - rituximab 1400 mg / 11.7 ml - rituximab
Israel -
hebreiska -
Ministry of Health
ריקסתון
novartis israel ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg / 1 ml - rituximab
Israel -
hebreiska -
Ministry of Health
מינג'ובי 200 מג
medison pharma ltd - tafasitamab - אבקה להכנת תמיסה מרוכזת לעירוי - tafasitamab 200 mg - tafasitamab
Israel -
hebreiska -
Ministry of Health
גזייבה
roche pharmaceuticals (israel) ltd - obinutuzumab - תרכיז להכנת תמיסה לאינפוזיה - obinutuzumab 1000 mg / 40 ml - obinutuzumab
Israel -
hebreiska -
Ministry of Health
קיפרוליס
amgen europe b.v. - carfilzomib - אבקה להכנת תמיסה לזריקה - carfilzomib 2 mg/ml - carfilzomib